Literature DB >> 15068445

Glaucoma from topical corticosteroids to the eyelids.

Helen M Garrott, Mark J Walland.   

Abstract

Raised intraocular pressure and glaucoma have rarely been associated with use of periorbital corticosteroids for dermatological conditions such as blepharitis and eczema. Three cases are described in which periorbital topical corticosteroids appear to have resulted in raised intraocular pressure or glaucoma. Topical corticosteroids used for dermatological conditions around the face and eyes are often regarded as being fairly innocuous with regard to ocular side-effects. This case series demonstrates that secondary open-angle glaucoma can be a sight-threatening consequence, and periorbital steroids should therefore be used cautiously and sparingly, particularly in those with a family history of glaucoma. Intraocular pressure may not always return to normal upon cessation of the drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068445     DOI: 10.1111/j.1442-9071.2004.00787.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  10 in total

1.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

2.  Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model.

Authors:  Karen Y Torrejon; Ellen L Papke; Justin R Halman; Judith Stolwijk; Cula N Dautriche; Magnus Bergkvist; John Danias; Susan T Sharfstein; Yubing Xie
Journal:  Biotechnol Bioeng       Date:  2015-12-30       Impact factor: 4.530

3.  Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.

Authors:  Michael W Marcus; Rogier P H M Müskens; Wishal D Ramdas; Roger C W Wolfs; Paulus T V M De Jong; Johannes R Vingerling; Albert Hofman; Bruno H C Stricker; Nomdo M Jansonius
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

Review 4.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

Review 5.  Etiopathogenesis of cataract: an appraisal.

Authors:  Varun B Gupta; Manjusha Rajagopala; Basavaiah Ravishankar
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

6.  Changes in Intraocular Pressure with Use of Periocular Triamcinolone Cream.

Authors:  Diana H Kim; Sana A Bautista; Elana Meer; Brendan McGeehan; Maureen G Maguire; César A Briceño
Journal:  J Ophthalmic Vis Res       Date:  2022-08-15

7.  Olive Pomace Phenolic Compounds: From an Agro-Industrial By-Product to a Promising Ocular Surface Protection for Dry Eye Disease.

Authors:  Nikolaos Katsinas; Uta Gehlsen; Laura García-Posadas; Soraya Rodríguez-Rojo; Philipp Steven; María J González-García; Amalia Enríquez-de-Salamanca
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

8.  Retrospective analysis of ocular adverse events with Clobetasol.

Authors:  Yu Wang; Joseph L Jorizzo
Journal:  Dermatol Ther       Date:  2022-05-29       Impact factor: 3.858

9.  Atopic dermatitis, cutaneous steroids and cataracts in children: two case reports.

Authors:  Andrew Tatham
Journal:  J Med Case Rep       Date:  2008-04-28

Review 10.  Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.

Authors:  Katarzyna Gutfreund; Wojciech Bienias; Anna Szewczyk; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.